About this policy
CMS evidence review | evidence_type=Technology Assessment | record_type=technology_assessment | document_id=54 | year=2008
Coverage indications
Positron emission tomography (PET) is a form of nuclear medicine imaging that detects and establishes metabolic abnormalities in tissue. A PET scanner produces an image of the area of interest through the detection of radiation emitted from a positron-emitting radionuclide that is introduced into the patient and that accumulates in the target tissue.
Documentation requirements
Associated Medcac: MEDCAC Meeting for FDG Positron Emission Tomography (PET) for 9 Cancers (brain, cervical, small cell lung, ovarian, pancreatic, testicular, prostate, bladder and kidney - 08/20/2008 Issue: Positron emission tomography (PET) is a form of nuclear medicine imaging that detects and establishes metabolic abnormalities in tissue. A PET scanner produces an image of the area of interest through the detection of radiation emitted from a positron-emitting radionuclide that is introduced into the patient and that accumulates in the target tissue. Other Material: Other Material 1 Questions: Questions Technology Assessment: Download Technology Assessment [PDF, 2MB] Download appendices [PDF, 3MB]
Codes in this policy
Code numbers and each code’s status as the policy records it. CPT code descriptions are left out of this page, as are the passages that cite CPT codes; the official document has them.
Backwork has no codes on record for this policy. Check the source.